FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 60 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q3 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $659,000 | -56.1% | 277,096 | -30.8% | 0.00% | – |
Q1 2019 | $1,502,000 | -9.7% | 400,534 | -13.6% | 0.00% | -100.0% |
Q4 2018 | $1,664,000 | -54.3% | 463,511 | -27.1% | 0.00% | 0.0% |
Q3 2018 | $3,645,000 | +45.1% | 636,127 | +26.9% | 0.00% | 0.0% |
Q2 2018 | $2,512,000 | -2.4% | 501,451 | -0.1% | 0.00% | 0.0% |
Q1 2018 | $2,575,000 | -20.0% | 501,831 | -6.4% | 0.00% | 0.0% |
Q4 2017 | $3,220,000 | +1.5% | 535,914 | -6.2% | 0.00% | 0.0% |
Q3 2017 | $3,172,000 | +25.5% | 571,639 | +4.9% | 0.00% | 0.0% |
Q2 2017 | $2,528,000 | +30.0% | 544,853 | +38.6% | 0.00% | 0.0% |
Q1 2017 | $1,945,000 | -66.3% | 393,004 | -24.5% | 0.00% | -50.0% |
Q4 2016 | $5,777,000 | +18.9% | 520,486 | -0.8% | 0.00% | +100.0% |
Q3 2016 | $4,857,000 | +38.7% | 524,474 | -4.9% | 0.00% | 0.0% |
Q2 2016 | $3,501,000 | -13.2% | 551,350 | -10.9% | 0.00% | 0.0% |
Q1 2016 | $4,033,000 | -23.6% | 618,580 | -4.9% | 0.00% | -50.0% |
Q4 2015 | $5,277,000 | -6.6% | 650,731 | -15.6% | 0.00% | 0.0% |
Q3 2015 | $5,648,000 | -16.0% | 770,559 | +17.5% | 0.00% | 0.0% |
Q2 2015 | $6,722,000 | – | 655,879 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|